Literature DB >> 19687314

Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study.

Pablo Conesa-Zamora1, Asunción Doménech-Peris, Francisco J Orantes-Casado, Sebastián Ortiz-Reina, Laura Sahuquillo-Frías, Jesús Acosta-Ortega, José García-Solano, Miguel Pérez-Guillermo.   

Abstract

In-depth study of cell cycle proteins and human papillomavirus (HPV) genotyping can provide useful information about the malignant potential of precursor lesions of cervical carcinoma (CC). Immunostaining of cell cycle-related proteins (p16, cyclin D1, Ki-67, p53, and ProEx C) was evaluated using tissue microarrays, and HPV genotypes were identified in 144 cervical tissue specimens encompassing normal or benign epithelial lesions, low- and high-grade squamous intraepithelial lesions (LSIL and HSIL, respectively), and CC. In addition, 14 cases with atypical immature metaplasia (AIM) were included to compare their immunohistochemical features with those of well-established precursor lesions. Expression of p16, Ki-67, and ProEx C was most associated with the severity of dysplasia. Positive expression of p16, Ki-67, and ProEx C and negative expression of p53 seem to be related to HPV-16 infection. AIM cases show an immunohistochemical pattern more similar to LSIL than to HSIL. Immunohistochemical assessment of cell cycle proteins may help to distinguish normal and benign conditions of the cervix from precursor lesions of CC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19687314     DOI: 10.1309/AJCPO0WY1VIFCYDC

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  26 in total

1.  A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.

Authors:  Christina S Kong; Andrew H Beck; Teri A Longacre
Journal:  Am J Surg Pathol       Date:  2010-07       Impact factor: 6.394

2.  MOLECULAR MARKERS OF EARLY CERVICAL NEOPLASIA.

Authors:  Alvaro P Pinto; Christopher P Crum; Michelle S Hirsch
Journal:  Diagn Histopathol (Oxf)       Date:  2010-10-01

3.  Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot.

Authors:  Renate Pichler; Wegene Borena; Georg Schäfer; Claudia Manzl; Zoran Culig; Sebastian List; Sabrina Neururer; Dorothee Von Laer; Isabel Heidegger; Helmut Klocker; Wolfgang Horninger; Hannes Steiner; Andrea Brunner
Journal:  World J Urol       Date:  2015-03-19       Impact factor: 4.226

4.  Diagnostic value of MCM2 immunocytochemical staining in cervical lesions and its relationship with HPV infection.

Authors:  Jian Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

5.  Krüppel-like factor 5 as potential molecular marker in cervical cancer and the KLF family profile expression.

Authors:  Daniel Marrero-Rodríguez; Keiko Taniguchi-Ponciano; Florinda Jimenez-Vega; Pablo Romero-Morelos; Monica Mendoza-Rodríguez; Alejandra Mantilla; Miriam Rodriguez-Esquivel; Daniel Hernandez; Angeles Hernandez; Guillermo Gomez-Gutierrez; Nancy Muñoz-Hernandez; Hugo Arreola-de la Cruz; Claudia Vargas-Requena; Cecilia Díaz-Hernández; Luis Serna-Reyna; Marco Meraz-Rios; Cindy Bandala; Jorge Ortiz-Leon; Mauricio Salcedo
Journal:  Tumour Biol       Date:  2014-08-15

6.  [Diagnosis and grading of cervical intraepithelial neoplasias].

Authors:  C Rosamilia; G Feichter; A Tzankov; E C Obermann
Journal:  Pathologe       Date:  2012-03       Impact factor: 1.011

7.  Using biomarkers as objective standards in the diagnosis of cervical biopsies.

Authors:  Mary T Galgano; Philip E Castle; Kristen A Atkins; William K Brix; Sarah R Nassau; Mark H Stoler
Journal:  Am J Surg Pathol       Date:  2010-08       Impact factor: 6.394

Review 8.  Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices.

Authors:  Rosa Catarino; Patrick Petignat; Gabriel Dongui; Pierre Vassilakos
Journal:  World J Clin Oncol       Date:  2015-12-10

9.  Evaluation of ProExC as a prognostic marker in oropharyngeal squamous cell carcinomas.

Authors:  Anne M Mills; Andrew H Beck; Nader Pourmand; Quynh Thu Le; Christina S Kong
Journal:  Am J Surg Pathol       Date:  2012-08       Impact factor: 6.394

10.  Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib.

Authors:  Zehua Wang; Jianwen Gao; Yuko Ohno; Haiou Liu; Congjian Xu
Journal:  Cancer Chemother Pharmacol       Date:  2020-01-06       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.